Thanks to our state-of-the-art facility, we can handle large volumes of samples, while maintaining our unprecedented precision and depth. We deliver projects with a fast turnaround time and routinely perform studies with over 1,000 samples for global pharma and biotech customers, academia, or consortia.
We process and store data with utmost protection and operate under comprehensive quality standards. We are GLP certified and compliant with GCP guidelines for the implementation of proteomics in clinical trials.
We stand for flexibility as well as scalability. We are flexible to support projects of different sizes and sample numbers, depending on the customer need. We operate at large scale according to today’s standards, and we are also fully equipped and capable to continuously scale up our throughput to support the rising capacity needs for large-scale proteomics in the future.
Our lab facility is operated by highly trained personnel with multiple years of proteomics expertise and extensive experience in the handling of various types of projects. Our lab personnel continuously develops and maintains the facility for optimal performance and uptime.
Our high-end mass spectrometers are set up with automated, tight spaced quality control. They can process samples from any species or biological matrices with high reproducibility.
With our facility of 900 square meters (9,687 square feet), we can scale up our throughput to 250,000 samples per year. We implement high throughput automation and parallelization for processing of samples on a large-scale, across many instruments.
Our IT infrastructure guarantees timely, error-free, and secure transfer of the mass spectrometric data. The resilient, in-house storage platform is prepared for huge future storage growth.
Our facility and processes conform with the highest quality standards for the processing of biological samples. Our services are performed in a professional manner, consistent with industry standards.
For pre-clinical studies our facility complies with the OECD principles and Swiss ordinance on GLP and is GLP-certified by the Swiss Health Authorities. For clinical studies requiring GCP compliance, we conform with the ICH E6 guideline and the EMA reflection paper for laboratories that analyze or evaluate clinical trial samples.
From our facility we invent and develop proprietary mass spectrometry-based proteomics technologies and offer a broad range of cutting-edge proteomics solutions. We make these widely available to life science researchers and proteomics experts to increase access to the proteome.